Actavis files ANDA for Reckitt generic with FDA
Generics | News | By BioSpectrum Bureau | 0 Comment | 10 Oct, 2013
Singapore: Actavis has filed an abbreviated new drug application (ANDA) with the US FDA seeking approval to market Bupre...Read more
Teva restructures organization model
Generics | News | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2014
Singapore: Global pharmaceutical company, Teva Pharmaceutical, is restructuring its management and organizational functi...Read more
Bayer appoints a new President
Generics | News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2014
Singapore: Bayer pharmaceuticals announced changes in the top management, declaring Mr Dieter Weinand as the president o...Read more
Lupin begins trial runs at Nagpur's Mihan unit
Generics | News | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2013
Mumbai: Indian drug giant Lupin Pharma has begun trial run at Mihan that it expects to become fully functional in two ye...Read more
Dr. Reddy's launches generic of Singulair oral granules
Generics | News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2012
Bangalore: India-based Dr. Reddy's Laboratories has launched its montelukast sodium oral granules, a bioequivalent gene...Read more
Daiichi Sankyo generics' unit to launch 5 drugs
Generics | News | By BioSpectrum Bureau | 0 Comment | 17 Dec, 2012
Singapore: Daiichi Sankyo's pharmaceuticals subsidiary, Daiichi Sankyo Espha is all set to launch five generic products ...Read more
Aurobindo receives FDA approval for Nevirapine
Generics | News | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2012
Bangalore: India-based Aurobindo Pharma has received final approval from the US Food & Drug Administration for Nevir...Read more
Another Indian pharma company rapped by FDA
Generics | News | By BioSpectrum Bureau | 0 Comment | 22 Oct, 2013
Singapore: After reports of Indian drug majors Ranbaxy Laboratories, Aurobindo Pharma, Dr Reddy's Laboratories and Wockh...Read more
Mitsubishi Tanabe files NDA for Canagliflozin
Generics | Regulatory | By BioSpectrum Bureau | 3 Comment | 30 May, 2013
Singapore: Mitsubishi Tanabe Pharma announced that the company has submitted an application for the manufacturing and ma...Read more
Mylan to develop, market Biocon generic insulin
Generics | News | By BioSpectrum Bureau | 0 Comment | 14 Feb, 2013
Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generi...Read more
Australia's Mayne Pharma launches Doryx in US
Generics | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013
Singapore: Mayne Pharma Group has announced the launch of Doxycycline Hyclate Delayed-Release tablet in the US through t...Read more
The US coaxing India to relax patent laws: MSF
Generics | News | By BioSpectrum Bureau | 0 Comment | 20 Oct, 2014
Singapore: Medical Charity, Medecins Sans Frontieres (MSF) has condemned the US for mounting pressure on India's new gov...Read more
FDA approves Novo Nordisk haemophilia A drug
Generics | Regulatory | By BioSpectrum Bureau | 3 Comment | 17 Oct, 2013
Singapore: U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's Biologics License Application (BLA) for r...Read more
Sun Pharma settles Gleevec compound litigation
Generics | Regulatory | By BioSpectrum Bureau | 4 Comment | 20 May, 2014
Singapore: Novartis Pharmaceuticals has reported to settle its litigation with US subsidiary of India based Sun Pharmace...Read more
Bayer's CEO to step down by 2016
Generics | News | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2014
Singapore: German drugmaker Bayer announced that Dr Marjin Dekkers will step down as the CEO, by the end of 2016. The fi...Read more
Lupin gets FDA approval for Lyrica generic
Generics | Regulatory | By BioSpectrum Bureau | 4 Comment | 06 Jul, 2012
Mumbai: Pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received final approval for its pregabalin capsules,...Read more
Indian state to slash prices of 348 drugs
Generics | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013
Singapore: Tripura has become the first Indian state to announce its implementation of the country's health ministry's d...Read more
Daiichi to work with US FDA to solve Ranbaxy quality issue
Generics | News | By BioSpectrum Bureau | 0 Comment | 25 Sep, 2013
Singapore: As a strong reaction to the import ban placed on Ranbaxy Laboratories' third manufacturing unit in India, the...Read more